LPL Financial’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-307
| Closed | -$5.19K | – | 5213 |
|
|
2024
Q3 | $5.19K | Buy |
307
+17
| +6% | +$287 | ﹤0.01% | 5040 |
|
|
2024
Q2 | $8.17K | Sell |
290
-290
| -50% | -$8.17K | ﹤0.01% | 4879 |
|
|
2024
Q1 | $174K | Buy |
580
+170
| +41% | +$51K | ﹤0.01% | 4466 |
|
|
2023
Q4 | $96.8K | Buy |
410
+280
| +215% | +$66.1K | ﹤0.01% | 4495 |
|
|
2023
Q3 | $19.5K | Buy |
130
+30
| +30% | +$4.5K | ﹤0.01% | 4548 |
|
|
2023
Q2 | $17.4K | Buy |
+100
| New | +$17.4K | ﹤0.01% | 4478 |
|
|
2021
Q3 | – | Sell |
-196
| Closed | -$46K | – | 4338 |
|
|
2021
Q2 | $46K | Hold |
196
| – | – | ﹤0.01% | 4127 |
|
|
2021
Q1 | $59K | Buy |
+196
| New | +$59K | ﹤0.01% | 3953 |
|